Abstract
Adhesion receptors are transmembrane proteins that mediate cell-cell and cell-matrix communications. In addition to their adhesive role in maintaining islet architecture, they are also important for promoting islet cell survival, proliferation and secretory function. Their capacity for improving β-cell mass and insulin secretion suggest that they may be suitable targets for pharmacological intervention, and their interactions with extracellular matrix proteins hold promise in improving islet transplantation outcomes. In this review, we have focused on integrins, cadherins and adhesion GPCRs, and highlight recent advances in their roles in islet function and discuss whether they could be targeted for diabetes therapy.
Crown Copyright © 2018. Published by Elsevier Ltd. All rights reserved.
Publication types
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Animals
-
Biomarkers / blood
-
Blood Glucose / drug effects*
-
Blood Glucose / metabolism
-
Cell Adhesion Molecules / metabolism*
-
Diabetes Mellitus / blood
-
Diabetes Mellitus / drug therapy*
-
Diabetes Mellitus / epidemiology
-
Diabetes Mellitus / pathology
-
Diffusion of Innovation
-
Drug Design*
-
Humans
-
Hypoglycemic Agents / adverse effects
-
Hypoglycemic Agents / therapeutic use*
-
Islets of Langerhans / drug effects*
-
Islets of Langerhans / metabolism
-
Islets of Langerhans / pathology
-
Molecular Targeted Therapy
-
Receptors, G-Protein-Coupled / drug effects*
-
Receptors, G-Protein-Coupled / metabolism
-
Signal Transduction / drug effects
Substances
-
Biomarkers
-
Blood Glucose
-
Cell Adhesion Molecules
-
Hypoglycemic Agents
-
Receptors, G-Protein-Coupled